Nexthera Capital »

Coherus Biosciences shares owned by Nexthera Capital

Quarter-by-quarter ownership of Coherus Biosciences (CHRS) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Coherus Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Coherus Biosciences held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coherus Biosciences by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $7.0M 316k 22.10

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Coherus Biosciences

Vanguard Group
BlackRock
Point72 Asset Management
Rubric Capital Management
Tang Capital Management
Kohlberg Kravis Roberts & Co
Geode Capital Management
State Street Corporation
Morgan Stanley
CM Management
CAM Group Holding A/S
AQR Capital Management
Thomas Stevens, CFA"
Millennium Management
Northern Trust

View all funds holding Coherus Biosciences